Fatima Karzai
Impact in
- Health Informatics top 2%
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- PARP inhibition in cancer therapy
Papers in
-
- Prostate Cancer Treatment and Research 66
- Prostate Cancer Diagnosis and Treatment 10
- Oncology 50
- Cancer Immunotherapy and Biomarkers 32
- Cancer Treatment and Pharmacology 8
- PARP inhibition in cancer therapy 7
- Co-authors
- James L. Gulley (76 shared papers)Ravi A. Madan (83 shared papers)William L. Dahut (64 shared papers)Marijo Bilušić (44 shared papers)Jeffrey Schlom (33 shared papers)Renee N. Donahue (23 shared papers)Julius Strauss (27 shared papers)Jennifer L. Marté (21 shared papers)
- Journals
- Journal of Clinical Oncology (45 papers)The Oncologist (11 papers)Annals of Oncology (10 papers)Cancer Research (4 papers)Clinical Genitourinary Cancer (4 papers)
- Partner nations
- United StatesItalyIndia
In The Last Decade
Fatima Karzai
101 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 93
- Health Informatics 58
- Oncology 549
- Immunology 332
- Cancer Research 199
- Pulmonary and Respiratory Medicine 363
Countries citing papers authored by Fatima Karzai
This map shows the geographic impact of Fatima Karzai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatima Karzai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatima Karzai more than expected).
Fields of papers citing papers by Fatima Karzai
This network shows the impact of papers produced by Fatima Karzai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatima Karzai. The network helps show where Fatima Karzai may publish in the future.
Co-authors
The 25 scholars most cited alongside Fatima Karzai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 204 | |
| 2 | 2018 | 160 | |
| 3 | 2023 | 77 | |
| 4 | 2014 | 54 | |
| 5 | 2019 | 53 | |
| 6 | 2019 | 49 | |
| 7 | 2021 | 47 | |
| 8 | 2020 | 42 | |
| 9 | 2020 | 41 | |
| 10 | 2016 | 39 | |
| 11 | 2018 | 36 | |
| 12 | 2024 | 29 | |
| 13 | 2017 | 26 | |
| 14 | 2012 | 25 | |
| 15 | 2021 | 21 | |
| 16 | 2023 | 19 | |
| 17 | 2019 | 19 | |
| 18 | 2017 | 18 | |
| 19 | 2022 | 18 | |
| 20 | 2022 | 17 |
About Fatima Karzai
Fatima Karzai is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 112 papers that have together received 1.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (66 papers), Cancer Immunotherapy and Biomarkers (32 papers), Immunotherapy and Immune Responses (16 papers), Cancer, Lipids, and Metabolism (11 papers), Prostate Cancer Diagnosis and Treatment (10 papers), Radiopharmaceutical Chemistry and Applications (10 papers), Cancer Treatment and Pharmacology (8 papers) and PARP inhibition in cancer therapy (7 papers). The work is most often cited by research in Health Informatics (58 citations), Oncology (549 citations), Immunology (332 citations), Cancer Research (199 citations) and Pulmonary and Respiratory Medicine (363 citations). Fatima Karzai has collaborated with scholars based in United States, Italy and India. Frequent co-authors include James L. Gulley, Ravi A. Madan, William L. Dahut, Marijo Bilušić, Jeffrey Schlom, Renee N. Donahue, Julius Strauss, Jennifer L. Marté, Lisa M. Cordes and Charalampos S. Floudas. Their work appears in journals such as Journal of Clinical Oncology, The Oncologist, Annals of Oncology, Cancer Research and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.